NASDAQ:ALKS
Alkermes plc Stock News
$24.26
+0.160 (+0.664%)
At Close: May 09, 2024
B of A Securities Maintains Neutral on Alkermes, Lowers Price Target to $17
12:00am, Monday, 23'rd Mar 2020Major Depressive Disorder (MDD) Market Insights, Epidemiology and Forecast to 2028 - ResearchAndMarkets.com
02:01pm, Friday, 20'th Mar 2020
The "Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering.
Is Alkermes (NASDAQ:ALKS) A Risky Investment?
10:05am, Friday, 20'th Mar 2020
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
Alyeska Investment Group L.P. Has $20.59 Million Stock Holdings in Alkermes Plc (NASDAQ:ALKS)
08:22am, Thursday, 19'th Mar 2020
Alyeska Investment Group L.P. boosted its holdings in shares of Alkermes Plc (NASDAQ:ALKS) by 2.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securiti
Controlled Release Drug Delivery Market Size Worth $69.8 Billion by 2027: Grand View Research, Inc.
07:35am, Thursday, 19'th Mar 2020
The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View Re
Alkermes Plc (ALKS) Director and CEO, Alkermes plc Richard F Pops Sold $–.– million of Shares
12:00am, Thursday, 19'th Mar 2020The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
11:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) * BioNTech SE - ADR (NASDAQ: BNTX) * Regeneron P
ProShare Advisors LLC Cuts Stake in Alkermes Plc (NASDAQ:ALKS)
10:10am, Wednesday, 18'th Mar 2020
ProShare Advisors LLC lowered its stake in shares of Alkermes Plc (NASDAQ:ALKS) by 18.1% in the fourth quarter, Holdings Channel reports. The firm owned 37,862 shares of the company’s stock after se
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
07:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) …
The "Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
Infinity Pharmaceuticals Augments Board of Directors with Appointment of Richard Gaynor, M.D.
11:35am, Tuesday, 17'th Mar 2020
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today the appointment of Richard Gaynor, M.D. to its Board of Directors, effective March 16, 2020.
Alkermes (ALKS) Down 8.6% Since Last Earnings Report: Can It Rebound?
03:30pm, Saturday, 14'th Mar 2020
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
